CELLUMED Co (XKRX:049180) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is CELLUMED Co 3-Year EBITDA Growth Rate?

CELLUMED Co's EBITDA per Share for the three months ended in Dec. 2024 was ₩-525.08.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of CELLUMED Co was 81.50% per year. The lowest was -44.30% per year. And the median was 37.10% per year.

Competitive Comparison of CELLUMED Co's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, CELLUMED Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CELLUMED Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CELLUMED Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where CELLUMED Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

CELLUMED Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

CELLUMED Co (XKRX:049180) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

CELLUMED Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of CELLUMED Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CELLUMED Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CELLUMED Co Ltd (XKRX:049180) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Acetechno Tower 9 402, Gasan-dong, Geumcheon-gu, Seoul, KOR, 153-782

Website

http://www.cellumed.co.kr

CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.

CELLUMED Co Headlines

No Headlines